國際醫療中心

The nation's premier pediatric disease treatment

The pediatrics department of our hospital has multiple specialties and sub-specialties and is a strong pediatric team. The hospital established a children's hospital in 2014, which will benefit more children and diseases at home and abroad. Dr. Lin Xuanpei of Genetics is well-known internationally. He has been treating and researching genetic rare diseases for many years, and has been invited to participate in relevant speeches and seminars at home and abroad for many times. MacKay memorial hospital is also a benchmark hospital in treating Childhood leukemia in Taiwan. The treatment mode, success rate, and international academic publication are second to none in Taiwan. The treatment of premature infants has accumulated decades of technology and experience and has rich experience in the successful treatment of the smallest weight in Taiwan. Premature Baby Foundation of Taiwan is one of the largest and most successful foundations in Taiwan. It is worth mentioning that the children's hematology and tumor team won the silver medal of the National Quality Mark Certification in 2019. The treatment effect of childhood leukemia is not only the first in Taiwan but also the first in Asia. It has published several internationally leading papers on behalf of the development of Many pioneer treatment schedules that have become the benchmark for reference treatment in various hospitals.

Features

1. Childhood Leukemia Team

2. Pediatric Brain Tumor Team

3. Pediatric Hematopoietic Stem Cell Transplantation Team

 

Advantages

Childhood Leukemia Team

1. The cure rate of childhood acute lymphoblastic leukemia is 95% in our institution

2. The cure rate of childhood acute myeloid leukemia is 80% in our institution

3. Childhood acute leukemia flow MRD detection, IgTCR MRD detection, fusion gene MRD detection

4. Childhood acute leukemia gene network and translational medicine research

 

Pediatric Brain Tumor Team

1. A  integrated clinical treatment team for pediatric brain tumors, including pediatric neurosurgery, pediatric neurology pediatric oncology, pediatric radiotherapy, neuroimaging, and neuropathology specialists.
2. Combined with target gene analysis, many diverse types of brain tumors in children can be analyzed individually and precisely targeted to achieve maximum efficacy.
3. Combined with translational medicine treatment strategies, from liquid biopsy to patient-derived xenograft mice model drug testing platform, to provide the best salvage treatment options for recurrent tumors.

 

Pediatric Hematopoietic Stem Cell Transplantation Team

1. Mackay Children's Transplantation Team specializes in various childhood cancer transplants, brain tumor transplants, solid tumor transplants, primary immunodeficiency disease transplants, rare disease transplants, and children's hematologic disease transplants
2. Mackay Children's Transplantation Team specializes in allogeneic hematopoietic stem cell transplantation for relatives, non-relatives, haploidentical relatives, umbilical cord blood transplantation, and CAR-T cell therapy

Mackay Children's medical team includes immune, heart, kidney, gastrointestinal, skin, critical care, children's surgery, pathology, radiation, pain, and tranquility teams. Each team has complete members, fully supports the children's transplant team, and provides comprehensive treatment assistance

Service items

Childhood Leukemia Team

1. Treatment of acute leukemia in children

2. Childhood acute leukemia flow MRD detection, IgTCR MRD detection, fusion gene MRD detection

3. Genetic network detection of childhood acute leukemia

4. Immunotherapy for childhood acute leukemia

 

Pediatric Brain Tumor Team

1. Navigation craniotomy
2. Intraoperative neurophysiological monitoring mapping function brain area
3. Mini-invasive neuroendoscopic biopsy、aspiration and tumor resection
4. Patient-derived xenograft mice model drug testing platform

 

Pediatric Hematopoietic Stem Cell Transplantation Team

1. Mackay Children's Transplantation Team specializes in various childhood cancer transplants, brain tumor transplants, solid tumor transplants, primary immunodeficiency disease transplants, rare disease transplants, and children's hematologic disease transplants

Mackay Children's Transplantation Team specializes in allogeneic hematopoietic stem cell transplantation for relatives, non-relatives, haploidentical relatives, umbilical cord blood transplantation, and CAR-T cell therapy

Our Teams

Director of Pediatric Hematology and Oncology: Dr. Yeh Ting-Chi (Pediatric Transplantation, Pediatric Oncology)

Member: Dr. Liu Hsi-Che (Pediatric Oncology)

Member: Dr. Hou Jen-Yin (Pediatric Oncology)

Member: Dr. Liang Muh-Lii (Pediatric Neurosurgery)

Member: Dr. Lei Wei-De (Pediatric Immunology)

Member: Dr. Fang Li-Jing (Pediatric Immunology)

Member: Dr. Yeh Shu-Ren (Pediatric Cardiology)

Member: Dr. Hung Wei-Li (Pediatric Cardiology)

Member: Dr. Tsi Cheng-Dao (Pediatric Nephrology)

Member: Dr. Lin Chi-Hua (Pediatric Nephrology)

Member: Dr. Lee Hong-Chang (Pediatric Gastroenterology)

Member: Dr. Jiang Chung-Bin (Pediatric Gastroenterology)

Member: Dr. Weng Shu-Chao (Pediatric Gastroenterology)

Member: Dr. Wu Yu-Hong (Pediatric Dermatology)

Member: Dr. Chao Yan-Jun (Pediatric Critical Care)

Member: Dr. Hsu Jing-Cheng (Pediatric Surgery)

Member: Dr. Chang Jia-Yu (Pediatric Surgery)

Member: Dr. Yeh Yi-Ting (Pediatric Surgery)

Member: Dr. Ting Wei-Hsin (Pediatric Neurology)

Member: Dr. Ho Che-Seng (Pediatric Neurology)

Member: Dr. Huang Jia-Yun (Pediatric Neurology)

Member: Dr. Wu Bao-shu (Pediatric Pathology)

Member: Dr. Tsi Pei-Shan (Pediatric Radiation)

Member: Dr. Huang Chun-Chao (Pediatric Neuroradiology)

Member: Dr. Yan Chong-Yu (Pediatric Hospice and palliative care, Pediatric Radiation Therapy)

Member: Physician Lao Suan-Chi (Pediatric Hospice and palliative care, Pediatric Anesthesiology)

Honors

1. 2019-2022 Interdisciplinary team therapy for children with acute lymphoblastic leukemia was selected as the national biotechnology quality SNQ certification, silver medal (the first team in Asia)

2. In 2012, it was selected as the most valuable team in the practice camp of the Medical Policy Association

3. 2013 Taipei City Health Bureau Medical Safety Quality Improvement Competition, Bronze Medal Award

4. Leader of Childhood Acute Lymphoblastic Leukemia Treatment Program in Taiwan (from 1993 to present)

5. Leader of Pediatric Germ Cell Tumor Treatment Program in Taiwan (since 2017 to date)

6. Leader of Pediatric Liver Tumor Treatment Program in Taiwan (since 2017 to date)

7. Pediatric brain tumor multi-specialty integrated clinic (the only one in Taiwan at present)

8. Hosted the Consensus Conference on Treatment Guidelines for Pediatric Germ Cell Tumors in Taiwan (2022/6/12)

9. Developing a targeted drug treatment model for childhood brain tumors: Abemaciclib, A Selective CDK4/6 Inhibitor, Restricts the Growth of Pediatric Ependymomas

Successful Case

1. The cure rate of childhood acute lymphoblastic leukemia is 95% in our institution

2. The cure rate of childhood acute myeloid leukemia is 80% in our institution

3. More than 80 cases of pediatric brain tumors and 20 cases of recurrent tumors have been successfully treated. The operative mortality rate was 0. The total surgical resection rate was 95%.

4. About 30 cases of children with brain tumors were treated with precision radiotherapy successfully.

5. About 50 cases of pediatric brain tumors were treated with targeted agents and chemotherapy successfully.

6. There are about 100 cases of a brain tumors in children in regular follow-up after successful treatment.

7. Autologous hematopoietic stem cell transplantation success rate: 100%

8. The success rate of allogeneic hematopoietic stem cell transplantation (including umbilical cord blood transplantation and haploidentical transplantation): 93%

9. More than 500 long-term survivors of childhood cancer to date continue to be followed-up